Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colonic Neoplasms × Sodium Chloride × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 8 Lung Neoplasms 5 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Hot Flashes 2 Glioblastoma 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Water-Electrolyte Imbalance 1 Surgical Wound 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Neoplasm, Residual 1 Lymphopenia 1 Lymphoma, Non-Hodgkin 1 Lymphedema 1 Lower Urinary Tract Symptoms 1 Locally Advanced Head and Neck Squamous Cell Carcinoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Hairy Cell 1 Hematologic Neoplasms 1 Heart Failure 1 Glioma 1 Gastrointestinal Neoplasms 1 Fatigue 1 Esophageal Neoplasms 1

Interventions

Fluorouracil 80 Oxaliplatin 73 Leucovorin 73 Irinotecan 68 Bevacizumab 45 Capecitabine 39 Cetuximab 36 Panitumumab 15 Folfox protocol 15 Floxuridine 11 Chemotherapy, Adjuvant 11 IFL protocol 9 Surgical Procedures, Operative 8 Neoadjuvant Therapy 8 Drug Therapy 8 trifluridine tipiracil drug combination 7 regorafenib 7 pembrolizumab 7 XELOX 7 Nivolumab 7 Radiotherapy 6 sargramostim 5 Trastuzumab 5 Melphalan 5 Immunohistochemistry 5 Dexamethasone 5 Celecoxib 5 Biopsy 5 tislelizumab 4 aflibercept 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04798612 2023-08-18

IPOS

Zealand University Hospital

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡